id: NEW:oud_treatment_medication_access_barriers_to_sud_medication_treatment_rate_oud
name: OUD Treatment Medication Access Barriers â†’ SUD Medication Treatment Rate (OUD)
from_node:
  node_id: NEW:oud_treatment_medication_access_barriers
  node_name: OUD Treatment Medication Access Barriers
to_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: SUD Medication Treatment Rate (OUD)
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Structural barriers including stigma, cost, transportation, and service availability limit
  initial access to OUD treatment medications'
- 'Step 2: Patients face challenges navigating healthcare systems to initiate medication-assisted treatment'
- 'Step 3: Complex regulatory requirements and limited provider availability reduce medication initiation
  rates'
- 'Step 4: Reduced treatment initiation leads to lower overall OUD medication treatment rates'
evidence:
  quality_rating: A
  n_studies: 47
  primary_citation: 'Natalie Lowry et al. 2024. "Patient experience of opioid use disorder treatment medications:
    a systematic review of contemporary qualitative research.." https://doi.org/10.1136/bmjopen-2024-088617'
  supporting_citations:
  - Studies published between 2005 and 2023 included in the systematic review
  - Additional citations require full-text access
  - 47 reports from qualitative and mixed methods studies
  doi: 10.1136/bmjopen-2024-088617
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Systematic review of 47 qualitative studies identified barriers to access as a major theme
  affecting patient experience of OUD treatment medications, with structural factors limiting medication
  initiation rates
spatial_variation:
  varies_by_geography: true
  variation_notes: Review included studies from community and criminal justice settings, suggesting geographic
    and institutional variation in access barriers
moderators:
- name: criminal_justice_involvement
  direction: strengthens
  strength: moderate
  description: Criminal justice settings present unique barriers to OUD treatment medication access
- name: stigma
  direction: strengthens
  strength: strong
  description: Social stigma identified as major theme affecting treatment initiation and continuation
structural_competency:
  equity_implications: This mechanism traces treatment access barriers to structural factors including
    healthcare system design, regulatory frameworks, and social stigma rather than individual patient
    motivation. The review explicitly endorses patient-centered care and clinically integrated services
    as structural solutions.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.741875'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
